Free Newsletter
Human/animal chimeras get a reprieve in the U.K.
After a huge outcry from scientists and patient groups, the U.K. has proposed legislation allowing the development of human/animal chimera embryos for research. Public Health had proposed banning the chimeras, triggering an outburst from critics who maintain the embryos are crucial for research into Parkinson's and other maladies. The animal/human embryos can be used in place of human eggs, which are often difficult to come by. The substitute is made by removing an animal cell nucleus and replacing it with the nucleus of a skin cell from a patient with a disease being studied. The hybrid is used to create embryonic stem cells for research. Under law, the chimeras would not be allowed to grow beyond 14 days and then would have to be discarded.
- here's the report from The Independent
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




